Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Eric Trie - Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
The Motley Fool

VanEck Pharmaceutical ETF (PPH -0.68%) provides concentrated exposure to global drugmakers, while iShares Global Healthcare ETF (IXJ -0.48%) offers broader access to the wider healthcare sector, including equipment and services companies. Investors…

thehindubusinessline.com - India pharma market enters US tariff transition with strong domestic growth: Report
India pharma market enters US tariff transition with strong domestic growth: Report
BusinessLine

India's pharmaceutical market is entering the proposed two-year transition period before the United States' planned tariffs on imported generic medicines with broad-based domestic growth momentum, according to an Equirus Securities report, which…

marketbeat.com - Organon & Co. Shareholders Clear Sun Pharma Merger Deal
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
MarketBeat

Merck, the Dow's hottest stock, gets set to report Q4 financials Shareholders of Organon & Co. NYSE: OGN approved the company's proposed merger agreement with Sun Pharmaceutical Holdings USA, Inc. at a virtual special meeting held Wednesday…

marketbeat.com - Nuvectis Pharma (NASDAQ:NVCT) Trading 1.1% Higher - Here's What Happened
Nuvectis Pharma (NASDAQ:NVCT) Trading 1.1% Higher - Here's What Happened
MarketBeat

Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s share price rose 1.1% during mid-day trading on Wednesday. The company traded as high as $19.75 and last traded at $19.29. Approximately 157,318 shares changed hands during mid-day trading, a…

marketbeat.com - Monashee Investment Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
Monashee Investment Management LLC Reduces Holdings in BridgeBio Pharma, Inc. $BBIO
MarketBeat

Monashee Investment Management LLC reduced its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 32.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The…

thehindubusinessline.com - Sensex, Nifty slide at open as West Asia crisis drives oil above $95; Dr Reddy's drags pharma
Sensex, Nifty slide at open as West Asia crisis drives oil above $95; Dr Reddy's drags pharma
BusinessLine

Benchmark indices opened lower on Thursday morning, weighed down by surging crude oil prices after Yemen's Houthi rebels attacked Saudi oil tankers, escalating the West Asia conflict and rattling investor sentiment across emerging markets. The BSE…

marketbeat.com - 177,500 Shares in Royalty Pharma PLC $RPRX Acquired by Andra AP fonden
177,500 Shares in Royalty Pharma PLC $RPRX Acquired by Andra AP fonden
MarketBeat

Andra AP fonden acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 177,500 shares of the…

marketbeat.com - NewAmsterdam Pharma Company N.V. $NAMS Stake Cut by Decheng Capital LLC
NewAmsterdam Pharma Company N.V. $NAMS Stake Cut by Decheng Capital LLC
MarketBeat

Decheng Capital LLC cut its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 45.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.

marketbeat.com - Bank of New York Mellon Corp Reduces Stock Position in Royalty Pharma PLC $RPRX
Bank of New York Mellon Corp Reduces Stock Position in Royalty Pharma PLC $RPRX
MarketBeat

Bank of New York Mellon Corp decreased its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,302,043…

japantimes.co.jp - Satviki Sanjay - Indian drugmakers rattled by Trump's 100% levy on generics
Indian drugmakers rattled by Trump's 100% levy on generics
The Japan Times

U.S. President Donald Trump's plan to impose steep tariffs on generic medicines has unsettled Indian drugmakers and put the spotlight on their strategy in their biggest export market. The NSE Nifty Pharma Index slipped 1.3% in Mumbai Wednesday…

statnews.com - Elaine Chen - New data on Eli Lilly's 'triple-G' drug leave open questions on heart benefit
New data on Eli Lilly's 'triple-G' drug leave open questions on heart benefit
STAT

Eli Lilly reported more results Thursday showing that its next-generation obesity drug is highly efficacious at weight loss, but the data from the study, focused on people with heart disease, aren't enough to answer a critical question about the…

washingtonexaminer.com - Kathleen Jaeger - Tariff India, and half of America's medicine cabinet could disappear
Tariff India, and half of America's medicine cabinet could disappear
Washington Examiner

The facts tell a different story. The U.S. has built a decadeslong partnership with India, which supplies nearly half of all generic medicines that millions of Americans trust. It should not be collateral damage in broader debates about trade…

scmp.com - Emma Ma - China's tycoons rein in charitable donations, switch focus to science, education
China's tycoons rein in charitable donations, switch focus to science, education
South China Morning Post

China's tycoons have reined in their charitable donations amid weaker-than-expected economic momentum, and among those that are still giving, many are redirecting their wealth towards advancing scientific development and supporting education. The…

bloomberg.com - Pratigya Vajpayee - India Rate-Hike Odds Rise as Pricey Crude Stokes Inflation Risk
India Rate-Hike Odds Rise as Pricey Crude Stokes Inflation Risk
Bloomberg

This article is for subscribers only. I'm Pratigya Vajpayee in New Delhi, looking at a pre-market setup that is pulling in different directions. Wednesday was a tough session. The Nifty 50 fell for a third straight day as pharma and large banks…

time.com - Philip Elliott - Debate Moment Captures Democrats' Troy Jackson Jitters
Debate Moment Captures Democrats' Troy Jackson Jitters
Time

Making sense of what matters most in Washington. By signing up you are agreeing to our Terms of Service and Privacy Policy. It should have been a layup. Instead, the question illustrated why some Democrats fear they are about to swap out Graham…

Receive a Daily briefing on Pharma Industry News

Get Started